检索结果-南通市图书馆

Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma(CHANCE001)

引用

Signal Transduction and Targeted Therapy 2023年第3期8卷 1198-1207页

作者： Hai-Dong Zhu Hai-Liang Li Ming-Sheng Huang Wei-Zhu yang guo-Wen Yin Bin-yan Zhong Jun-hui Sun Zhi-cheng Jin Jian-Jian chen Nai-Jian Ge Wen-Bin Ding Wen-hui Li Jin-Hua Huang Wei Mu Shan-Zhi Gu Jia-Ping Li hui Zhao Shu-Wei Wen yan-Ming Lei Yu-Sheng Song chun-Wang Yuan Wei-Dong Wang Ming Huang Wei Zhao Jian-Bing wu Song Wang Xu Zhu Jian-Jun Han Wei-Xin Ren Zai-Ming Lu Wen-Ge Xing Yong Fan Hai-Lan Lin Zi-Shu zhang guo-hui Xu Wen-Hao Hu Qiang Tu Hong-Ying Su Chuan-Sheng Zheng Yong chen Xu-Ya Zhao Zhu-Ting fang Qi Wang Jin-Wei Zhao Ai-Bing Xu Jian Xu Qing-Hua wu Huan-zhang Niu Jian Wang Feng Dai Dui-Ping Feng Qing-Dong Li Rong-Shu Shi Jia-Rui Li Guang yang Hai-Bin Shi Jian-Song Ji Yu-E liu Zheng Cai Po yang yang Zhao Xiao-Li Zhu Li-Gong Lu Gao-Jun Teng Center of Interventional Radiology&Vascular Surgery Department of RadiologyZhongda HospitalMedical SchoolSoutheast UniversityNanjing 210009China department of Minimally invasive Intervention The Affiliated Cancer Hospital of Zhengzhou UniversityZhengzhou 450008China department of Interventional Radiology the Third Affiliated HospitalSun Yat-Sen UniversityGuangzhou 510630China department of Interventional Radiology Union Hospital of Fujian Medical UniversityFuzhou 350001China department of Interventional Radiology Jiangsu Cancer Hospital&Jiangsu Institute of Cancer Research&The Affiliated Cancer Hospital of Nanjing Medical UniversityNanjing 210009China department of Interventional Radiology The First Affiliated Hospital of Soochow UniversitySoochow UniversitySuzhou 215006China Hepatobiliary and Pancreatic Interventional Treatment Center Division of Hepatobiliary and Pancreatic SurgeryThe First Affiliated HospitalZhejiang University School of MedicineHangzhou 310003China department of Interventional Radiology Eastern Hospital of Hepatobiliary SurgeryNavy Medical University(Second Military Medical University)Shanghai 200438China department of Interventional Radiology Nantong First People’s HospitalNantong 226001China department of Interventional Radiology Yancheng Third People’s HospitalYancheng 224008China department of Minimally Invasive Interventional Therapy Sun YatSen University Cancer CenterGuangzhou 510060China department of Vascular Surgery Southwest HospitalThird Military Medical University(Army Medical University)Chongqing 400038China. department of Interventional Radiology Hunan Cancer HospitalChangsha 410031China department of Interventional Oncology The First Affiliated Hospital of Sun Yat-sen UniversityGuangzhou 510080China department of Interventional Radiology The Hospital of Nantong UniversityNantong 226001China department of Interventional Therapy Shanxi Tumor HospitalTaiyuan 030001China department of Interventional Radiology Tibet Autonomous Region People’s

There is considerable potential for integrating transarterial chemoembolization(TACE),programmed death-(ligand)1(PD-[L]1)inhibitors,and molecular targeted treatments(MTT)in hepatocellular carcinoma(HCC).It is necessary to investigate the therapeutic efficacy and safety of TACE combined with PD-(L)1 inhibitors and MTT in real-world *** this nationwide,retrospective,cohort study,826 HCC patients receiving either TACE plus PD-(L)1 blockades and MTT(combination group,n=376)or TACE monotherapy(monotherapy group,n=450)were included from January 2018 to May *** primary endpoint was progression-free survival(PFS)according to modified *** secondary outcomes included overall survival(OS),objective response rate(ORR),and *** performed propensity score matching approaches to reduce bias between two *** matching,228 pairs were included with a predominantly advanced disease *** PFS in combination group was 9.5 months(95%confidence interval[CI],8.4-11.0)versus 8.0 months(95%CI,6.6-9.5)(adjusted hazard ratio[HR],0.70,P=0.002).OS and ORR were also significantly higher in combination group(median OS,19.2[16.1-27.3]vs.15.7 months[13.0-20.2];adjusted HR,0.63,P=0.001;ORR,60.1%vs.32.0%;P<0.001).Grade 3/4 adverse events were observed at a rate of 15.8%and 7.5%in combination and monotherapy groups,*** results suggest that TACE plus PD-(L)1 blockades and MTT could significantly improve PFS,OS,and ORR versus TACE monotherapy for Chinese patients with predominantly advanced HCC in real-world practice,with an acceptable safety profile.

关键词： hepatocellular targeted matching

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

肺癌适应性治疗中国专家共识

引用

循证医学 2024年第4期24卷 193-200页

作者：吴一龙陆舜程颖周清张嘉涛潘燚汪斌超韩宝惠陈海泉周清华王绿化陈明王洁周彩存刘晓晴马智勇黄诚宋启斌莫树锦钟文昭朱正飞宋勇陈蓉蓉陈克终刘基巍杨帆胡晓桦胡毅杨懿岳东升王群赵军范江陈椿孟庆威闫小龙董晓荣朱波邢力刚李兆澄李子明褚倩陈元林根段建春田攀文范云刘安文刘慧刘哲峰杨农汪步海张同梅信涛刘思阳王志杰马锐于起涛林劼涂海燕姚煜赵明芳王慧娟张海波蔡尚立张绪超李慧杜瀛瀛吴芳严令华崔久嵬王燕邬麟周建娅汪笑男黄媚娟冯卫能周进李力中国抗癌协会肺癌专业委员会广东省临床试验协会/中国胸部肿瘤研究协作组广东省肺癌研究所南方医科大学附属广东省人民医院(广东省医学科学院)广州510080 上海交通大学医学院附属胸科医院上海200030 吉林省肿瘤医院长春130021 复旦大学附属肿瘤医院上海200032 四川大学华西医院成都610041 中国医学科学院肿瘤医院深圳医院广东深圳518116 中山大学肿瘤防治中心广州510060 中国医学科学院肿瘤医院北京100021 同济大学附属上海市肺科医院上海200433 解放军总医院第五医学中心北京100039 郑州大学附属肿瘤医院/河南省肿瘤医院郑州450003 福建省肿瘤医院福州350011 武汉大学人民医院肿瘤中心武汉430060 香港中文大学医学院中国香港东部战区总医院南京210002 北京吉因加科技有限公司北京102206 北京大学人民医院北京100044 大连医科大学附属第一医院辽宁大连116011 广西医科大学第一附属医院南宁530020 解放军总医院北京100071 成都市第三人民医院/西南交通大学医学院成都610031 天津医科大学肿瘤医院天津300060 复旦大学附属中山医院上海200032 北京大学肿瘤医院北京100142 上海交通大学附属上海市第一人民医院上海200025 福建医科大学附属协和医院福州350001 哈尔滨医科大学附属肿瘤医院哈尔滨150081 空军军医大学唐都医院西安710038 华中科技大学同济医学院附属协和医院武汉430022 陆军军医大学第二附属医院-新桥医院重庆400037 山东省肿瘤医院济南250117 华中科技大学同济医学院附属同济医院武汉430030 中国医学科学院肿瘤医院山西医院太原030013 中国科学院大学附属肿瘤医院/浙江省肿瘤医院杭州310022 南昌大学附属第二医院南昌330006 湖南省第二人民医院长沙410035 南京大学医学院附属苏北人民医院江苏扬州225001 首都医科大学附属北京胸科医院北京101149 哈尔滨医科大学附属第二医院哈尔滨150001 暨南大学附属第一医院广州510630 辽宁省肿瘤医院沈阳110042 广西医科大学附属肿瘤医院南宁530012 昆明医科大学第二附属医院昆明650101 西安交通大学第一附属医院西安710061 中国医科大学附属第一医院沈阳110001 广东省中医院广州510120 广州燃石医学检验所有限公司广州510300 安徽医科大学第一附属医院合肥230022 中南大学湘雅二医院长沙410011 上海桐树生物科技有限公司上海200444 吉林大学白求恩第一医院长春130021 湖南省肿瘤医院长沙410013 浙江大学医学院附属第一医院杭州310031 南京世和基因生物技术股份有限公司南京210032 佛山市第一人民医院广东佛山528000 四川省肿瘤医院成都610042 陆军军医大学大坪医院重庆400042 不详

由中国抗癌协会肺癌专业委员会和广东省临床试验协会/中国胸部肿瘤研究协作组主办的“第21届中国肺癌高峰论坛”于2024年3月2日在广州顺利召开。此次论坛以肺癌适应性治疗为主题,从肺癌适应性治疗定义、早中晚期临床应用以及生物标志物... 详细信息

由中国抗癌协会肺癌专业委员会和广东省临床试验协会/中国胸部肿瘤研究协作组主办的“第21届中国肺癌高峰论坛”于2024年3月2日在广州顺利召开。此次论坛以肺癌适应性治疗为主题,从肺癌适应性治疗定义、早中晚期临床应用以及生物标志物对适应性治疗的指导价值等角度展开探讨并达成了专家共识。

关键词：肺癌适应性治疗共识

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Radiofrequency ablation for hepatic hemangiomas: A consensus from a Chinese panel of experts

引用

World Journal of Gastroenterology 2017年第39期23卷 7077-7086页

作者： Jun Gao Rui-fang Fan Jia-Yin yang yan cui Jian-Song Ji Kuan-Sheng Ma Xiao-Long Li Long zhang Chong-Liang Xu Xin-Liang Kong Shan Ke Xue-Mei Ding Shao-Hong Wang Meng-Meng yang Jin-Jin Song Bo Zhai chun-Ming Nin Shi-Gang guo Zong-Hai Xin Jun Lu Yong-Hong Dong Hua-Qiang Zhu Wen-Bing Sun department of Hepatobiliary Surgery Beijing Chaoyang Hospital Affiliated to Capital Medical University department of Hepatobiliary Surgery Lanzhou General Hospital of Lanzhou Military Region Center of Liver Transplantation West China Hospital Sichuan University department of General Surgery the 306th Hospital of Chinese people’s Liberation Army department of Radiology Lishui Central Hospital The Fifth Affiliated Hospital of Wenzhou Medical College Institute of Hepatobiliary Surgery Southwest Hospital The Third Military Medical University department of General Surgery Affiliated Hospital of Chifeng University department of Hepatobiliary Surgery Rizhao People’s Hospital department of Tumor Intervention Renji Hospital Shanghai Jiao Tong University School of Medicine department of General Surgery Chaoyang Central Hospital department of General Surgery Zhanhua People’s Hospital department of General Surgery Shandong Provincial People’s Hospital department of General Surgery Shanxi Provincial People’s Hospital

Recent studies have shown that radiofrequency(RF) ablation therapy is a safe, feasible, and effective procedure for hepatic hemangiomas, even huge hepatic hemangiomas. RF ablation has the following advantages in the treatment of hepatic hemangiomas: minimal invasiveness, definite efficacy, high safety, fast recovery, relatively simple operation, and wide applicability. It is necessary to formulate a widely accepted consensus among the experts in china who have extensive expertise and experience in the treatment of hepatic hemangiomas using RF ablation, which is important to standardize the application of RF ablation for the management of hepatic hemangiomas, regarding the selection of patients with suitable indications to receive RF ablation treatment, the technical details of the techniques, therapeutic effect evaluations, management of complications, etc. A final consensus by a Chinese panel of experts who have the expertise of using RF ablation to treat hepatic hemangiomas was reached by means of literature review, comprehensive discussion, and draft approval.

关键词： Hepatic hemangiomas Radiofrequency ablation Consensus

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

遗传性耳聋基因治疗临床指南

引用

实用医院临床杂志 2024年第2期21卷 39-44页

作者：齐洁玉谈方志张李燕陆玲王洪阳李文妍刘闻闻付小龙贺祖宏丁小琼孙珊方巧军董耀东朱学伟童步升曹现宝郭敏范欣淼汪芹马璐张天虹于亚峰李永新樊建刚崔勇吴佩娜张宏征唐杰郭维维查定军叶放蕾何双八曹卫杨见明钱晓云赵宇孙敬武陈晓巍孙宇夏明王秋菊袁慧军冯永孔维佳杨仕明王海波高下李华伟徐磊柴人杰东南大学数字医学工程全国重点实验室附属中大医院耳鼻咽喉头颈外科生命科学与技术学院生命与健康高等研究院江苏省生物医学高新技术研究重点实验室江苏南京210096 南通大学神经再生联合创新中心江苏南通226001 北京理工大学航天中心医院神经内科生命学院北京10081 南京大学医学院附属鼓楼医院耳鼻喉头颈外科江苏省医学重点学科(实验室)江苏南京210008 中国人民解放军总医院耳鼻咽喉头颈外科医学部北京100853 听觉与平衡觉全国重点实验室北京100853 国家耳鼻咽喉疾病临床医学研究中心北京100853 聋病教育部重点实验室北京100853 聋病防治北京市重点实验室北京100853 复旦大学附属眼耳鼻喉科医院医学神经生物学国家重点实验室教育部脑科学前沿研究中心上海200031 复旦大学生物医学研究所上海200032 国家卫健委听觉医学重点实验室上海200031 复旦大学脑科学研究院和脑科学协同创新中心上海200032 山东大学山东省耳鼻喉医院耳鼻咽喉头颈外科山东济南250022 山东省耳鼻喉研究所山东济南250022 山东第一医科大学/山东省医学科学院医学科技创新中心山东济南250000 武汉大学中南医院耳鼻咽喉头颈外科湖北武汉430071 东南大学附属中大医院耳鼻咽喉头颈外科江苏南京210009 复旦大学附属眼耳鼻喉科医院耳鼻喉科上海200032 安徽医科大学第二附属医院耳鼻咽喉头颈外科安徽合肥230601 中国医科大学附属盛京医院耳鼻咽喉头颈外科辽宁沈阳110004 吉林大学中日联谊医院耳鼻咽喉头颈外科吉林长春130033 安徽医科大学第一附属医院耳鼻咽喉头颈外科安徽合肥230022 云南省第一人民医院耳鼻喉科云南昆明650032 昆明医科大学第一附属医院耳鼻喉科云南昆明650032 中国医学科学院北京协和医学院北京协和医院耳鼻咽喉科北京100730 中南大学湘雅二医院耳鼻咽喉头颈外科湖南长沙410008 南华大学衡阳医学院基础医学院细胞生物学与遗传学教研室细胞应激生物学衡阳市重点实验室湖南衡阳421001 哈尔滨医科大学附属第一医院黑龙江哈尔滨150001 苏州大学附属第一医院耳鼻咽喉科江苏苏州215006 首都医科大学附属北京同仁医院耳鼻咽喉头颈外科北京100730 四川省医学科学院·四川省人民医院/电子科技大学附属医院耳鼻咽喉头颈外科四川成都610072 广东省人民医院耳鼻咽喉头颈外科/广东省医学科学院/南方医科大学广东广州510080 南方医科大学珠江医院耳鼻咽喉头颈外科广东广州510282 空军军医大学西京医院耳鼻咽喉-头颈外科陕西西安710032 郑州大学第一附属医院耳科河南郑州450000 东南大学医学院附属南京同仁医院耳鼻咽喉头颈外科江苏南京211102 四川大学华西医院耳鼻咽喉头颈外科四川成都610041 中国科学技术大学附属第一医院耳鼻咽喉头颈外科安徽合肥230001 华中科技大学同济医学院附属协和医院耳鼻咽喉头颈外科湖北武汉430022 山东第一医科大学附属山东省立医院耳鼻咽喉科山东济南250021 山东省医学科学院医学科技创新中心山东济南250021 山东大学附属山东省立医院耳鼻咽喉科山东济南250021 国家卫生健康委耳鼻咽喉重点实验室山东济南250021 四川大学华西医院罕见病研究院四川成都6010041 南华大学衡阳医学院南华大学附属妇幼保健院湖南长沙410008 中南大学湘雅医院耳鼻咽喉头颈外科湖南长沙410008 上海人工耳蜗工程技术研究中心上海200031 东南大学深圳研究院广东深圳518063

遗传性耳聋是一种常见的遗传性疾病,新生儿的发病率为1‰~3‰。患者终身携带致病突变,导致不可逆性耳聋,至今尚无临床可用的治疗药物。在部分遗传性耳聋动物模型中,基因治疗已被证实为潜在有效的治疗方法。国内外已开展了多项遗传性耳... 详细信息

遗传性耳聋是一种常见的遗传性疾病,新生儿的发病率为1‰~3‰。患者终身携带致病突变,导致不可逆性耳聋,至今尚无临床可用的治疗药物。在部分遗传性耳聋动物模型中,基因治疗已被证实为潜在有效的治疗方法。国内外已开展了多项遗传性耳聋基因治疗的临床试验。其中,由东南大学附属中大医院牵头,联合国内多家医院成功开展的遗传性耳聋基因治疗临床试验,取得了显著的疗效,并积累了丰富的经验。为规范遗传性耳聋基因治疗并提供临床研究指导,全国多家医院的耳科专家讨论制定了遗传性耳聋基因治疗临床指南,内容涵盖了伦理审查、遗传性耳聋的诊断和入组标准、临床前准备、药物、疗效与安全性评估标准、术后言语康复等。本指南将为耳聋基因治疗的临床诊疗提供规范的理论和技术指导。

关键词：遗传性耳聋基因治疗临床指南

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

2015-2021年CHINET临床分离肠杆菌属细菌耐药性变迁

引用

中国感染与化疗杂志 2024年第3期24卷 309-317页

作者：闫少珍孙自镛陈中举杨洋胡付品朱德妹谢轶康梅张峰波季萍胡志东李金郭素芳沈瀚周万青徐英春张小江徐雪松鄢超王传清付盼贾伟李刚徐元宏黄颖郭大文赵金英刘文恩李艳明喻华黄湘宁单斌杜艳王山梅楚亚菲倪语星孙景勇俞云松林洁卓超苏丹虹魏莲花邹凤梅金炎邵春红李继红张利侠马娟褚云卓田素飞段金菊康建邦汪瑞忠房华胡芳芳胡云建艾效曼董方吕志勇张泓王春赵勇龚萍朱镭孟晋华马晓波郑燕萍吴劲松卢月梅郭如意朱焱温开镇张贻荣岳春雷刘江山黄文辉薛顺虹胡雪飞顾洪芹冯佼周树平周艳陈运生孟青俞碧霞沈继录窦睿王世富贺雯廖龙凤姜琳华中科技大学同济医学院附属同济医院检验科武汉430030 复旦大学附属华山医院抗生素研究所四川大学华西医院新疆医科大学第一附属医院天津医科大学总医院内蒙古医科大学附属医院南京大学医学院附属鼓楼医院中国医学科学院北京协和医院吉林大学中日联谊医院复旦大学附属儿科医院宁夏医科大学总医院安徽医科大学第一附属医院哈尔滨医科大学附属第一医院中南大学湘雅医院四川省人民医院昆明医科大学第一附属医院河南省人民医院上海交通大学医学院附属瑞金医院浙江大学医学院附属邵逸夫医院广州医科大学附属第一医院甘肃省人民医院山东省立医院河北医科大学第二医院陕西省人民医院中国医科大学附属第一医院山西医科大学第二医院上海市浦东新区人民医院贵州省人民医院北京医院首都医科大学附属北京儿童医院上海交通大学医学院附属儿童医院湖北省秭归县人民医院山西省儿童医院厦门大学附属第一医院深圳市人民医院福建省泉州市第一医院福建省晋江市医院吉林省九台区人民医院甘肃省金昌市中西医结合医院青海大学附属医院青海省互助县人民医院南昌大学第一附属医院山东省广饶县人民医院四川省邻水县人民医院江西省儿童医院深圳市儿童医院浙江宁波市镇海龙赛医院安徽医科大学第四附属医院安徽省亳州市利辛县人民医院山东大学齐鲁儿童医院辽宁省营口市经济技术开发区中心医院江西省赣县区人民医院河南省辉县市人民医院

目的监测2015-2021年中国主要地区53所医疗机构临床分离肠杆菌属细菌分布及耐药性变迁。方法对全国53所医院在2015-2021年临床分离的肠杆菌属细菌按CHINET统一监测方案采用纸片扩散法或商品化药敏试验自动测试仪进行抗菌药物敏感性试验... 详细信息

目的监测2015-2021年中国主要地区53所医疗机构临床分离肠杆菌属细菌分布及耐药性变迁。方法对全国53所医院在2015-2021年临床分离的肠杆菌属细菌按CHINET统一监测方案采用纸片扩散法或商品化药敏试验自动测试仪进行抗菌药物敏感性试验,依据2021年CLSI M100判读药敏结果,采用WHONET 5.6软件进行数据分析。结果2015-2021年共检出肠杆菌属细菌37966株,七年间,肠杆菌属细菌在所有临床分离菌株中的分布呈波动性变化趋势,占总体菌株的2.5%,在肠杆菌目细菌中占5.7%。肠杆菌属细菌以阴沟肠杆菌为主,为93.7%(35571/37966)。菌株主要分离自呼吸道样本,7年平均为(44.4±4.6)%,其次是分泌物/脓液样本,为(16.4±2.3)%,尿液样本为(16.0±0.9)%。在变化趋势上,阴沟肠杆菌在呼吸道样本的分布呈下降趋势,无菌体液样本的分布呈增长趋势。37966株肠杆菌属细菌主要分离自住院患者,为92.9%,门急诊患者为(7.1±0.8)%。住院患者中以外科病房患者的分离株最多,为(24.4±2.9)%。从药敏结果分析,阴沟肠杆菌对阿米卡星、替加环素、多黏菌素B、亚胺培南、美罗培南的耐药率≤7.9%;阿氏肠杆菌的耐药率则≤5.6%,但对多黏菌素B的耐药率高于阴沟肠杆菌(19.7%对3.9%);日沟维肠杆菌则对阿米卡星、替加环素、亚胺培南、美罗培南的耐药率≤8.1%,但对多黏菌素B的耐药率为10.5%。七年间,碳青霉烯类耐药的肠杆菌属细菌总体检出率为10.0%,呈逐年上升的趋势。不同科室患者分离株对不同抗菌药物的耐药率存在较大差异,成人与儿童患者分离菌株对抗菌药物的耐药率也不尽相同,碳青霉烯类耐药的阴沟肠杆菌以ICU患者样本检出率最高。结论CHINET细菌耐药监测显示2015-2021年肠杆菌属细菌的分布呈现锯齿型变化,并对多种抗菌药物耐药率增加,尤其是对碳青霉烯类的耐药率呈逐年增长的趋势。

关键词：肠杆菌属阴沟肠杆菌细菌耐药监测碳青霉烯类耐药

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

The heterogeneity of islet autoantibodies and the progression of islet failure in type 1 diabetic patients

引用

science china(Life sciences) 2016年第9期59卷 930-939,938-939+932-937页

作者： Jin liu lingling Bian Li Ji yang chen Heng chen Yong Gu Bingqin Ma Wei Gu Xinyu Xu Yun Shi Jian Wang Dalong Zhu Zilin Sun Jianhua Ma hui Jin Xing Shi Heng Miao Bing Xin yan Zhu Zhenwen zhang Ruifang Bu Lan Xu Guangde Shi Wei Tang Wei Li Dongmei Zhou Jun Liang Xingbo cheng Bimin Shi Jixiang Dong Ji Hu chen fang Shao Zhong Weinan Yu Weiping Lu chenguang wu Li Qian Jiancheng Yu Jialin Gao Xiaoqiang Fei Qingqing zhang Xueqin Wang Shiwei cui Jinluo cheng Ning Xu guofeng Wang guoqing Han chunrong Xu Yun Xie Minmin An Wei zhang Zhixiao Wang Yun Cai Qi Fu Yu Fu Shuai Zheng Fan yang Qingfang Hu Hao Dai Yu Jin Zheng zhang Kuanfeng Xu Yifan Li Jie Shen Hongwen Zhou Wei He Xuqin Zheng Xiao Han Liping Yu Jinxiong She Mei zhang Tao yang department of Endocrinology and Metabolism First Affiliated Hospital of Nanjing Medical University Nanjing 210029 China Barbara Davis Center for Childhood Diabetes University of Colorado Denver Aurora Colorado 80045 USA Key Laboratory of Human Functional Genomics of Jiangsu Province Nanjing Medical University Nanjing 210000 China department of Isotopic Laboratory of Nanjing medical university Nanjing 210000 China HLA Laboratory of Jiangsu Province People's hospital Nanjing 210029 China department of Endocrinology and Metabolism Nanjing General Hospital of Nanjing Military Command Nanjing 210002 China department of Endocrinology and Metabolism Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School Nanjing 210008 China department of Endocrinology and Metabolism Zhongda Hospital Southeast University Nanjing 210009 China department of Endocrinology and Metabolism Nanjing First Hospital Nanjing 210000 China department of Endocrinology and Metabolism Nanjing Children's Hospital Nanfing 210008 China department of Endocrinology and Metabolism The Second Affiliated Hospital of Nanjing Medical University Nanjing 210011 China department of Endocrinology and Metabolism Nanjing Governmental Hospital Nanjing 210008 China department of Endocrinology and Metabolism Northern Jiangsu People's Hospital Yangzhou 225001 China department of Endocrinology and Metabolism Wuxi People's Hospital Wuxi 214023 China department of Endocrinology and Metabolism Jiangsu Jiangyin People's Hospital Wuxi 214400 China department of Endocrinology and Metabolism The Affiliated Hospital of Xuzhou Medical College Xuzhou 221006 China department of Endocrinology and Metabolism Xuzhou Central Hospital Xuzhou 221009 China department of Endocrinology and Metabolism The First Affiliated Hospital of Soochow University Suzhou 215006 China department of Endocrinology and Metabolism The Second Affiliated Hospital of Soochow University Suzhou 215004 China department of Endocri

Type 1 diabetes mellitus is heterogeneous in many facets. The patients suffered from type 1 diabetes present several levels of islet function as well as variable number and type of islet-specific autoantibodies. This study was to investigate prevalence and heterogeneity of the islet autoantibodies and clinical phenotypes of type 1 diabetes mellitus; and also discussed the process of islet failure and its risk factors in Chinese type 1 diabetic patients. A total of 1,291 type 1 diabetic patients were enrolled in this study. Demographic information was collected. Laboratory tests including mixed-meal tolerance test, human leukocyte antigen alleles, hemoglobin A1 c, lipids, thyroid function and islet autoantibodies were conducted. The frequency of islet-specific autoantibody in newly diagnosed T1 DM patients(duration shorter than half year) was 73% in East china. According to binary logistic regressions, autoantibody positivity, longer duration and lower Body Mass Index were the risk factors of islet failure. As the disease developed, autoantibodies against glutamic acid decarboxylase declined as well as the other two autoantibodies against zinc transporter 8 and islet antigen 2. The decrease of autoantibodies was positively correlated with aggressive beta cell destruction. Autoantibodies can facilitate the identification of classic T1 DM from other subtypes and predict the progression of islet failure. As there were obvious heterogeneity in autoantibodies and clinical manifestation in different phenotypes of the disease, we should take more factors into consideration when identifying type 1 diabetes mellitus.

关键词： autoantibodies heterogeneity islet failure type 1 diabetes

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

A Search for Solar Axions and Anomalous Neutrino Magnetic Moment with the Complete Panda X-Ⅱ Data

引用

Chinese Physics Letters 2021年第1期38卷 30-34页

作者： Xiaopeng Zhou Xinning Zeng Xuyang Ning Abdusalam Abdukerim Wei chen Xun chen Yunhua chen chen cheng Xiangyi cui Yingjie Fan Deqing fang Changbo Fu Mengting Fu Lisheng Geng Karl Giboni Linhui Gu Xuyuan guo Ke Han Changda He Di Huang yan Huang yanlin Huang Zhou Huang Xiangdong Ji Yonglin Ju Shuaijie Li Huaxuan liu Jianglai liu Xiaoying Lu Wenbo Ma Yugang Ma Yajun Mao Yue Meng Kaixiang Ni Jinhua Ning Xiangxiang Ren Changsong Shang guofang Shen Lin Si Andi Tan Anqing Wang Hongwei Wang Meng Wang qiuhong Wang Siguang Wang Wei Wang Xiuli Wang Zhou Wang Mengmeng wu Shiyong wu Weihao wu Jingkai Xia Mengjiao Xiao Pengwei Xie Binbin yan Jijun yang Yong yang chunxu Yu Jumin Yuan Ying Yuan Dan zhang Tao zhang Li Zhao Qibin Zheng Jifang Zhou Ning Zhou INPAC School of Physics and AstronomyShanghai Jiao Tong Universityand Shanghai Key Laboratory for Particle Physics and CosmologyShanghai 200240China School of Physics Beihang UniversityBeijing 100191China Shanghai Jiao Tong university Sichuan Research Institute Chengdu 610213China Yalong River Hydropower Development Company Ltd.288 Shuanglin RoadChengdu 610051China School of Physics Sun Yat-Sen UniversityGuangzhou 510275China Tsung-Dao Lee Institute Shanghai Jiao Tong UniversityShanghai 200240China School of Physics Nankai UniversityTianjin 300071China Key Laboratory of Nuclear Physics and Ion-Beam Application(MOE) Institute of Modern PhysicsFudan UniversityShanghai 200433China School of Physics Peking UniversityBeijing 100871China International Research Center for Nuclei and Particles in the Cosmos&Beijing Key Laboratory of Advanced Nuclear Materials and Physics Beihang UniversityBeijing 100191China School of medical Instrument and Food Engineering University of Shanghai for Science and TechnologyShanghai 200093China department of Physics University of MarylandCollege ParkMaryland 20742USA School of Mechanical Engineering Shanghai Jiao Tong UniversityShanghai 200240China School of Physics and Key Laboratory of Particle Physics and Particle Irradiation(MOE) Shandong UniversityJinan 250100China Shanghai Institute of Applied Physics Chinese Academy of SciencesShanghai 201800China Shanghai Advanced Research Institute Chinese Academy of SciencesShanghai 201210China Center for High Energy Physics Peking UniversityBeijing 100871China

We report a search for new physics signals using the low energy electron recoil events in the complete data set from PandaX-Ⅱ,in light of the recent event excess reported by XENON1 *** data correspond to a total exposure of 100.7 ton·day with liquid *** robust estimates of the dominant background spectra,we perform sensitive searches on solar axions and neutrinos with enhanced magnetic *** is found that the axionelectron coupling gAe2) for an axion mass less than 0.1 keV/c^(2) and the neutrino magnetic moment μv<4.9×10^(-11)μB at 90%confidence *** observed excess from XENON1 T is within our experimental constraints.

关键词： moment. excess estimates

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Prevalence, awareness, treatment, and control of hypertension in the non-dialysis chronic kidney disease patients

引用

Chinese medical Journal 2013年第12期126卷 2276-2280页

作者： ZHENG Ying CAI Guang-yan chen Xiang-mei FU Ping chen Jiang-hua DING Xiao-qiang YU Xue-qing LIN Hong-li liu Jian XIE Ru-juan WANG Li-ning NI Zhao-hui liu Fu-you YIN Ai-ping XING Chang-ying WANG Li SHI Wei liu Jian-she HE Ya-ni DING guo-hua LI Wen-ge wu Guang-li MIAO Li-ning chen Nan SU Zhen MEI Chang-lin ZHAO Jiu-yang GU Yong BAI Yun-kai LUO hui-min LIN Shan chen Meng-hua GONG Li yanG Yi-bin yanG Xiao-ping LI Ying WAN Jian-xin WANG Nian-song LI Hai-ying XI chun-sheng HAO Li XU yan fang Jing-ai liu Bi-cheng LI Rong-shan WANG Rong zhang Jing-hong WANG Jian-qin LOU Tan-qi SHAO Feng-min MEI Feng liu Zhi-hong YUAN Wei-jie SUN Shi-ren zhang ling ZHOU chun-hua chen Qin-kai JIA Shun-lian GONG Zhi-feng GUAN Guang-ju XIA Tian ZHONG Liang-bao department of Nephrology State key Laboratory of Kidney Disease Chinese PLA General Hospital Beijing 100853 China Nephrology Institute of the Chinese People's Liberation Army Chinese People's Liberation Army Key Laboratory of Nephrology Beijing 100853 China department of Nephrology West China Hospital of Sichuan University Chengdu Sichuan 610041 China department of Nephrology First Affiliated Hospital School of Medicine Zhejiang University Hangzhou Zhejiang 310003 China department of Nephrology Zhongshan Hospital Fudan University Shanghai 200032 China department of Nephrology First Affiiated Hospital of Sun Yat-sen University Guangzhou Guangdong 510080 China department of Nephrology First Affiliated Hospital of Dalian Medical University Dalian Liaoning 116011 China department of Nephrology First Affiliated Hospital of Xinjiang Medical University Urumqi Xinjiang 830054 China department of Nephrology First Affiliated Hospital of Harbin Medical University Harbin Heilongjiang 150001 China department of Nephrology First Afftiated Hospital of China Medical University Shenyang Liaoning 110001 China department of Nephrology Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai 200025 China department of Nephrology Second Xiangya Hospital Central South University Changsha Hunan 410000 China department of Nephrology First Affiliated Hospital of Medical College Xi'an Jiaotong University Xi'an Shaanxi 710061 China department of Nephrology First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital) Nanjing Jiangsu 210029 China department of Nephrology Sichuan Provincial People's Hospital Chengdu Sichuan 610072 China department of Nephrology Guangdong Provincial People's Hospital Guangzhou Guangdong 510030 China department of Nephrology Affliated Xiehe Hospital Tongji Medical College Huazhong Science and Technology University Wuhan Hubei 430022 China department of Nephrology Daping Hospital Third Military Medi

Background Data on the epidemiology of hypertension in Chinese non-dialysis chronic kidney disease （CKD） patients are *** aim of the present study was to investigate the prevalence,awareness,treatment,and control of hypertension in the non-dialysis CKD patients through a nationwide,multicenter study in *** The survey was performed in 61 tertiary hospitals in 31 provinces,municipalities,and autonomous regions in china （except Hong Kong,Macao,and Taiwan）.Trained physicians collected demographic and clinical data and measured blood pressure （BP） using a standardized *** was defned as systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg,and/or use of antihypertensive *** 〈140/90 mmHg and 〈130/80 mmHg were used as the 2 thresholds of hypertension *** multivariate logistic regression with adjustment for sex and age,we analyzed the association between CKD stages and uncontrolled hypertension in non-dialysis CKD *** The analysis included 8927 non-dialysis CKD *** prevalence,awareness,and treatment of hypertension in non-dialysis CKD patients were 67.3%,85.8%,and 81.0%,*** hypertensive CKD patients,33.1% and 14.1% had controlled BP to 〈140/90 mmHg and 〈130/80 mmHg,*** successive CKD stages,the prevalence of hypertension in non-dialysis CKD patients increased,but the control of hypertension decreased （P〈0.001）.When the threshold of BP 〈130/80 mmHg was considered,the risk of uncontrolled hypertension in CKD 2,3a,3b,4,and 5 stages increased 1.3,1.4,1.4,2.5,and 4.0 times compared with CKD 1 stage,respectively （P〈0.05）.Using the threshold of 〈140/90 mmHg,the risk of uncontrolled hypertension increased in advanced stages （P〈0.05）.Conclusions The prevalence of hypertension Chinese non-dialysis CKD patients was high,and the hypertension control was *** successive CKD stages,the risk of uncontrolled hypertension increased.

关键词： non-dialysis chronic kidney disease chronic kidney disease stages hypertension epidemiology

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Consensus statement on layout and delivery of automatic external defibrillator in china

引用

Journal of Hainan medical university 2020年第15期26卷 18-23页

作者： Yu Cao Song chen yan-Fen Chai Xiao-hui chen Yu-guo chen Shao-Wen cheng Wen-Wei cheng Bang-Han Ding yang Deng Jie Fu Bang-Jiang fang Mai-Ying Fan Li Gui Ping Gong Wei guo Shu-Bin guo Liang Huang Ji-Yuan Han Zhong Ji Xian-Fei Ji Xin-Cai Ji Hong-Xu Jin Xin-Jun Jiang Wang-Xiang Jiang Jia-Liang liu Xiao-Ran liu Zhi liu Chuan-Zhu Lv Feng Lu Tan-Shi Li Xin Li Yong Li Shang-Lun Li Shuang-Ming Li Xiao-Gang Li Bao-Jun Li Pei-wu Li chun-Sheng Li Zhi-Jun Li Chang-Luo Li Xiang-Min Li Yin-Ping Li Zong-Jun Lu Zu-Xun Lu Zhong-qiu Lu Zhi-Qian Luo Xiao-Xing Liao Jian-Bo Lei Tao Ma Yu Ma Yue-Feng Ma Qing-Bian Ma Lin-Hao Ma Jun-Qi Ma Shi-Nan Nie Jie-Miao Ou-yang Peng Peng Qiao Pei Shu-Ming Pan guo-Zhong Qing Li-Jie Qin wu-Ying Qiao Fei Shao Wei Song Xing-Yue Song Zhen-Ju Song Rong-Ju Sun De-Ya Shang Du-Juan Sha Gui-Lan Tao guo-Gang Tian Ying-Ping Tian Jian-Guang Tian Chao-yang Tong Zi-Ren Tang Meng-Xiong Tang guo-Ping wu Zhi Wan Tao Wang Xin Wang Peng Wang Zhong Wang Tong Wang Ri-Xing Wang Yi-Xin Wang Xiao-Dan Wang ling wu Wei Wei Hua Xiang Feng Xu Jun Xu Jie Xu Miao-Rong Xie Shuo-Gui Xu Tie Xu Feng Yu Wen Yi Li-Shan yang Shi-Jiao yan Jin-Jian Yao Shou-chun yan Xue-Zhong Yu Xian-Zhi Ye Xian-Liang yan Fu-Bing Zhou Rong-Bin Zhou Ming Zhou Qiang Zhou Jin Zhou Ping Zhou Chang-Ju Zhu Hua-Dong Zhu Ji-Hong Zhu Hong zhang Mao zhang Hua zhang Na zhang guo-Qiang zhang guo-Xiu zhang Jin-Song zhang Wen-wu zhang Wen-Zhong zhang Jian-Feng zhang Yi-Min Zhu Jun Zeng Yuan Zheng Zhi-Jie Zheng Shen Zhao yan Zhao Min Zhao Bin Zhao Xiao-Dong Zhao Xiao-Jing Zhao Hong-Ke Zeng Sheng-Qiang Zou The Chinese Society of Emergency Medicine Research Unit of Island Emergency Medicine Chinese Academy of Medical SciencesHainan Medical University Key Laboratory of Emergency and Trauma of Ministry of Education Hainan Medical UniversityHaikouHainanChina Emergency and Trauma college Hainan Medical UniversityHaikouHainanChina department of Emergency Hainan Clinical Research Center for Acute and Critical DiseasesThe Second Affiliated Hospital of Hainan Medical UniversityHaikouHainanChina Key Laboratory of Hainan Trauma and Disaster Rescue Key Laboratory of Trauma of Hainan medical university

*** Sudden cardiac death(SCD)refers to sudden death due to a variety of cardiac *** is manifested as a sudden loss of consciousness,cardiac arrest,and respiratory arrest and generally shows early symptoms that are atypical and not easily detected[1].According to a recent study,nearly 544000 patients suffer from SCD every year in china[2].

关键词： cardiac death respiratory

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Study of background from accidental coincidence signals in the PandaX-Ⅱexperiment

引用

Chinese Physics C 2022年第10期46卷 11-24页

作者： Abdusalam Abdukerim Wei chen Xun chen Yunhua chen chen cheng Xiangyi cui Yingjie Fan Deqing fang Changbo Fu Mengting Fu Lisheng Geng Karl Giboni Linhui Gu Xuyuan guo Ke Han Changda He Di Huang yan Huang yanlin Huang Zhou Huang Xiangdong Ji Yonglin Ju Shuaijie Li Huaxuan liu Jianglai liu Wenbo Ma Yugang Ma Yajun Mao Yue Meng Kaixiang Ni Jinhua Ning Xuyang Ning Xiangxiang Ren Changsong Shang Lin Si guofang Shen Andi Tan Anqing Wang Hongwei Wang Meng Wang qiuhong Wang Siguang Wang Wei Wang Xiuli Wang Zhou Wang Mengmeng wu Shiyong wu Weihao wu Jingkai Xia Mengjiao Xiao Pengwei Xie Binbin yan Jijun yang Yong yang chunxu Yu Jumin Yuan Ying Yuan Xinning Zeng Dan zhang Tao zhang Li Zhao Qibin Zheng Jifang Zhou Ning Zhou Xiaopeng Zhou School of Physics and Astronomy Shanghai Jiao Tong UniversityMOE Key Laboratory for Particle Astrophysics and CosmologyShanghai Key Laboratory for Particle Physics and CosmologyShanghai 200240China Shanghai Jiao Tong university Sichuan Research Institute Chengdu 610213China Yalong River Hydropower Development Company Ltd.288 Shuanglin RoadChengdu 610051China School of Physics Sun Yat-Sen UniversityGuangzhou 510275China Tsung-Dao Lee Institute Shanghai 200240China School of Physics Nankai UniversityTianjin 300071China Key Laboratory of Nuclear Physics and Ion-beam Application(MOE) Institute of Modern PhysicsFudan UniversityShanghai 200433China School of Physics Peking UniversityBeijing 100871China School of Physics Beihang UniversityBeijing 102206China Beijing Key Laboratory of Advanced Nuclear Materials and Physics Beihang UniversityBeijing102206China School of Physics and Microelectronics Zhengzhou UniversityZhengzhouHenan 450001China School of medical Instrument and Food Engineering University of Shanghai for Science and TechnologyShanghai 200093China department of Physics University of MarylandCollege ParkMaryland 20742USA School of Mechanical Engineering Shanghai Jiao Tong UniversityShanghai 200240China School of Physics and Key Laboratory of Particle Physics and Particle Irradiation(MOE) Shandong UniversityJinan 250100China Shanghai Institute of Applied Physics Chinese Academy of SciencesShanghai 201800China Shanghai Advanced Research Institute Chinese Academy of SciencesShanghai 201210China Center for High Energy Physics Peking UniversityBeijing 100871China

Ⅰ.INTRODUCTION The direct detection of dark matter particles,especially the weakly interacting massive particles(WIMPs),is being actively carried out by a couple of experiments worldwide[1].In recent years,the PandaX-Ⅱ experiment located in the china Jinping Underground Laboratory(CJPL)[1-3],which uses the technology of dual phase liquid xenon time projection chambers(TPCs),has pushed the limits of the cross section between WIMPs and nucleons to a new level for most of the possible WIMP masses;other experiments of the same type are also being performed[4–10].

关键词： dark matter xenon detector background accidental coincidence machine learning

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：